1 马凤莲,刘奇志,刘俊,等.红细胞分布宽度与冠心病的相关性研究[J].中华老年心脑血管病杂志,2013,15(3):258-261.
2 Mandras SA,Ventura HO,Corris PA. Breaking Down the Barriers:Why the Delay in Referral for Pulmonary Arterial Hypertension[J]. Ochsner J,2016,16(3):2572-62.
3 谢能轩,熊志泉,郑丽梅,等.血清胱抑素C和β2-微球蛋白在糖尿病肾病诊断中的临床意义[J].中国实验诊断学,2012,16(3):441-443.
4 Sinha SK,Khanra D,Jha MJ,et al. Unusual Survival of Anomalous Left Coronary Artery From the Pulmonary Artery With Severe Rheumatic Mitral Stenosis in Septuagenarian Women:Foes Becoming Friends[J]. J Clin Med Res,2016,8(10):760-763.
5 陈果,何建国,柳志红,等.不同类型肺动脉高压患者临床特征和血流动力学的比较分析[J].中国循环杂志,2013,28(4):300-303.
6 郑晓可.慢性阻塞性肺疾病合并肺动脉高压患者血清C-反应蛋白和内皮素-1水平测定及临床意义研究[J].中国全科医学,2012,15(25):2899-2901.
7 隋东昕,王伟,徐少华,等.慢性阻塞性肺疾病继发肺动脉高压患者血清超敏C反应蛋白水平变化及意义[J].山东医药,2012,52(46):66-67.
8 Prior DL,Adams H,Williams TJ. Update on pharmacotherapy for pulmonary hypertension[J]. Med J Aust,2016,205(6):271-276.
9 张金彪,胡海涛,刘玉欣,等.改良NAP活性检测在慢性阻塞性肺疾病急性加重期诊治中的应用价值[J].山东医药,2016,56(12):65-67.
10 张伟,俞同福,徐海,等.CT肺动脉成像对急性肺栓塞患者肺动脉高压严重程度的评估[J].放射学实践,2013,28(3):324-328.
11 Anderson RJ,Malhotra A,Kim NH. Pulmonary hypertension:evolution of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension[J]. J Thorac Dis,2016,8(7):562-565.
12 蒋延文,庞莉,方秋红,等.血清炎性因子水平与慢性阻塞性肺疾病继发肺动脉高压的相关性研究[J].中华结核和呼吸杂志,2011,34(12):904-908.
13 陈小容,邹霞英,辛达临,等.慢性阻塞性肺疾病合并不同程度肺动脉高压的临床比较[J].广东医学,2013,34(18):2792-2795.
14 Mahran Y,Schueler R,Weber M,et al. Noninvasive model including right ventricular speckle tracking for the evaluation of pulmonary hypertension[J]. World J Cardiol,2016,8(8):472-480.
15 Qin N,Yang W,Feng D,et al. Total ginsenosides suppress monocrotaline-induced pulmonary hypertension in rats:involvement of nitric oxide and mitogen-activated protein kinase pathways[J]. J Ginseng Res. 2016. 40(3):285-291.
16 衣欣,胡奉环.红细胞分布宽度对老年慢性心力衰竭患者预后的影响研究[J].中国全科医学,2013,16(16):1859-1861. |